Exubera NDA Will Be Filed "Early" In 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer will file for approval of inhaled insulin in the U.S. in early 2005, Worldwide R&D President John Lamattina said during Pfizer's Nov. 30 analysts meeting in Groton, Conn